The Activity of 1,8-Dihydroanthraquinone Derivatives in Nervous System Cancers
Author Information
Author(s): Okoń Estera, Kukula-Koch Wirginia, Jarząb Agata, Gaweł-Bęben Katarzyna, Bator Ewelina, Michalak-Tomczyk Magdalena, Jachuła Jacek, Antosiewicz-Klimczak Beata, Odrzywolski Adrian, Koch Wojciech, Wawruszak Anna
Primary Institution: Medical University of Lublin
Hypothesis
The review analyzes the anticancer properties of 1,8-dihydroanthraquinone derivatives in treating nervous system cancers.
Conclusion
1,8-Dihydroanthraquinone derivatives show potential as effective treatments for nervous system cancers by inducing apoptosis and reducing tumor cell proliferation.
Supporting Evidence
- 1,8-Dihydroanthraquinone derivatives induce apoptosis and necrosis in cancerous cells.
- These compounds can disrupt DNA transcription and replication in rapidly dividing cells.
- They alter ROS levels, leading to oxidative stress that damages tumor cells.
- 1,8-Dihydroanthraquinone derivatives influence signaling pathways involved in oncogenesis.
Takeaway
This study looks at how certain natural compounds from plants can help fight brain cancer by making cancer cells die and stopping them from growing.
Methodology
The review summarizes findings from various studies on the effects of 1,8-dihydroanthraquinone derivatives on nervous system cancers, including in vitro and in vivo models.
Limitations
The review primarily focuses on in vitro studies, with limited in vivo data available.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website